Cargando…

The Expression of Vasoactive Intestinal Peptide Receptor 1 Is Negatively Modulated by MicroRNA 525-5p

BACKGROUND: The human Vasoactive Intestinal Peptide (VIP) is a neurokine with effects on the immune system where it is involved in promoting tolerance. In this context, one of its receptors, VPAC1, has been found to be down-modulated in cells of the immune network in response to activating stimuli....

Descripción completa

Detalles Bibliográficos
Autores principales:	Cocco, Elisa, Paladini, Fabiana, Macino, Giuseppe, Fulci, Valerio, Fiorillo, Maria Teresa, Sorrentino, Rosa
Formato:	Texto
Lenguaje:	English
Publicado:	Public Library of Science 2010
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2919398/ https://www.ncbi.nlm.nih.gov/pubmed/20706588 http://dx.doi.org/10.1371/journal.pone.0012067

Ejemplares similares

Single Nucleotide Polymorphisms in the 3′UTR of VPAC-1 Cooperate in Modulating Gene Expression and Impact Differently on the Interaction with miR525-5p
por: Paladini, Fabiana, et al.
Publicado: (2014)

Role of vasoactive intestinal peptide in osteoarthritis
por: Jiang, Wei, et al.
Publicado: (2016)

Vasoactive intestinal peptide secreting tumour: An overview
por: Una Cidon, Esther
Publicado: (2022)

HLA Class I or Class II and Disease Association: Catch the Difference If You Can
por: Fiorillo, Maria Teresa, et al.
Publicado: (2017)

Vasoactive intestinal peptide axis is dysfunctional in patients with Graves’ disease
por: Carrión, M., et al.
Publicado: (2020)

HLA-E gene polymorphism associates with ankylosing spondylitis in Sardinia
por: Paladini, Fabiana, et al.
Publicado: (2009)

Vasoactive intestinal peptide producing pheochromocytoma and intracardiac thrombosis
por: Hermel, Melody, et al.
Publicado: (2021)

Epitranscriptomics: A New Layer of microRNA Regulation in Cancer
por: De Paolis, Veronica, et al.
Publicado: (2021)

The Multifaceted Nature of Aminopeptidases ERAP1, ERAP2, and LNPEP: From Evolution to Disease
por: Paladini, Fabiana, et al.
Publicado: (2020)

MicroRNA-525 enhances chondrosarcoma malignancy by targeting F-spondin 1
por: Liu, Bo, et al.
Publicado: (2019)

Select cognitive deficits in Vasoactive Intestinal Peptide deficient mice
por: Chaudhury, Dipesh, et al.
Publicado: (2008)

Nonneuronal cells mediate neurotrophic action of vasoactive intestinal peptide
Publicado: (1987)

The effects of vasoactive intestinal peptide on RANKL-induced osteoclast formation
por: Qu, Hongyi, et al.
Publicado: (2021)

Chronic Diarrhea Caused by Vasoactive Intestinal Peptide-Secreting Tumor
por: Belei, Oana, et al.
Publicado: (2023)

Adenosine-to-Inosine Editing of Vasoactive MicroRNAs Alters Their Targetome and Function in Ischemia
por: van der Kwast, Reginald V.C.T., et al.
Publicado: (2020)

A negative trial for vasoactive intestinal peptide in COVID-19-associated acute hypoxaemic respiratory failure
por: Lee, Warren L, et al.
Publicado: (2023)

Serum Levels of Vasoactive Intestinal Peptide as a Prognostic Marker in Early Arthritis
por: Martínez, Carmen, et al.
Publicado: (2014)

Comprehensive RNA dataset of AGO2 associated RNAs in Jurkat cells following miR-21 over-expression
por: Carissimi, Claudia, et al.
Publicado: (2016)

Ankylosing Spondylitis: A Trade Off of HLA-B27, ERAP, and Pathogen Interconnections? Focus on Sardinia
por: Paladini, Fabiana, et al.
Publicado: (2019)

The emerging multifunctional roles of ERAP1, ERAP2 and IRAP between antigen processing and renin-angiotensin system modulation
por: Mattorre, Benedetta, et al.
Publicado: (2022)

Vasoactive Intestinal Peptide and Its Receptors in Human Ovarian Cortical Follicles
por: Gabbay-Benziv, Rinat, et al.
Publicado: (2012)

Therapeutic effect of vasoactive intestinal peptide on form-deprived amblyopic kittens
por: Li, Bo, et al.
Publicado: (2019)

Vasoactive intestinal peptide regulates ileal goblet cell production in mice
por: Schwerdtfeger, Luke A., et al.
Publicado: (2020)

Hypercalcemia in a Patient Diagnosed with a Vasoactive Intestinal Peptide Tumor
por: Ataallah, Basma, et al.
Publicado: (2020)

Vasoactive intestinal peptide in canine portosystemic shunt in the absence of portal hypertension
por: Isaka, Mitsuhiro, et al.
Publicado: (2021)

Pressure-Dependent Elevation of Vasoactive Intestinal Peptide Level in Chicken Choroid
por: Privalov, Evgeny, et al.
Publicado: (2023)

Microarray dataset of Jurkat cells following miR-93 over-expression
por: Gioiosa, Silvia, et al.
Publicado: (2016)

Clostridium difficile suppresses colonic vasoactive intestinal peptide associated with altered motility
por: Nassif, A., et al.
Publicado: (1995)

Prospect of vasoactive intestinal peptide therapy for COPD/PAH and asthma: a review
por: Wu, Dongmei, et al.
Publicado: (2011)

Role of Vasoactive Intestinal Peptide in Promoting the Pathogenesis of Eosinophilic Esophagitis (EoE)
por: Verma, Alok K., et al.
Publicado: (2017)

Serum substance P and vasoactive intestinal peptide levels in infants with acute intussusception
por: Zhu, Zhen-chuang, et al.
Publicado: (2019)

Recent advances in vasoactive intestinal peptide physiology and pathophysiology: focus on the gastrointestinal system
por: Iwasaki, Mari, et al.
Publicado: (2019)

Vasoactive Intestinal Peptide-Secreting Pancreatic Neuroendocrine Tumor: A Case Report
por: Thivacaren, Sritharan, et al.
Publicado: (2022)

Vasoactive Intestinal Peptide-Secreting Pheochromocytoma: A Case Report and Review of Literature
por: Yee, Shelby K., et al.
Publicado: (2022)

Vasoactive intestinal peptide–VIPR2 signaling regulates tumor cell migration
por: Asano, Satoshi, et al.
Publicado: (2022)

Vasoactive Intestinal Peptide Tumor as the Cause of Persistent Diarrhea: A Diagnostic Challenge
por: Lopes, Sara, et al.
Publicado: (2022)

The Impact of the ‘Mis-Peptidome’ on HLA Class I-Mediated Diseases: Contribution of ERAP1 and ERAP2 and Effects on the Immune Response
por: Tedeschi, Valentina, et al.
Publicado: (2020)

Protective effect of vasoactive intestinal peptide on bone destruction in the collagen-induced arthritis model of rheumatoid arthritis
por: Juarranz, Yasmina, et al.
Publicado: (2005)

The Anti-Inflammatory Mediator, Vasoactive Intestinal Peptide, Modulates the Differentiation and Function of Th Subsets in Rheumatoid Arthritis
por: Villanueva-Romero, Raúl, et al.
Publicado: (2018)

Rat Cerebellar Grafts Have (125)I-Vasoactive Intestinal Peptide Binding Sites
por: Moody, T. W., et al.
Publicado: (1992)

Cannot write session to /tmp/vufind_sessions/sess_038r13idqr17q736035hr7kqdu